z-logo
Premium
P3‐078: Pupil dilation during a cognitive task: A psychophysiological biomarker differentiating early MCI and normal cognitive function
Author(s) -
Kremen William S.,
Granholm Eric,
Panizzon Matthew,
Franz Carol,
Hauger Richard,
Jak Amy J.,
Liu Weijian,
Xian Hong,
Lyons Michael
Publication year - 2015
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2015.06.945
Subject(s) - pupillometry , pupillary response , cognition , psychology , biomarker , dilation (metric space) , audiology , neuropsychology , effects of sleep deprivation on cognitive performance , pupil , developmental psychology , medicine , neuroscience , biochemistry , mathematics , combinatorics , chemistry
these levels with commonly used AD biomarker, amyloid beta 1-42 (Ab1-42). Methods:The study included 20 patients with MCI and 20 elderly individuals without cognitive impairment. The CSF concentrations of MMP-9 and Ab1-42 were determined using ELISA method. We also assessed the diagnostic sensitivity and area under ROC curves (AUC) of MMP-9 and Ab1-42in differentiation between MCI patients and non-demented controls. Results:Concentrations of Ab1-42 in MCI group and normal controls were 642 pg/mL and 1090 pg/mL, respectively. The CSF levels of MMP-9 were significantly lower inMCI patients (Median 107 pg/mL, p<0.001) in comparison with elderly individuals without cognitive impairment (Median 447 pg/mL). Additionally, ratios of CSF levels of MMP-9 to Ab1-42 in MCI patients (0.15, p<0.001) were significantly lower than in control group (0.45). Moreover, the percentage of positive results for MMP-9 (95%) was higher than for Ab1-42 (60%), whereas AUCs were 0.985 for MMP-9 and 0.763 for Ab1-42. Conclusions:Our findings suggest that MMP-9 might play a role in the development of mild cognitive impairment and could be a good candidate for the diagnostic biomarker of the early stage of dementia, although this issue requires further elucidation.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here